Emcyte Corporation

EmCyte Corporation® is the worlds leader in autologous Platelet Rich Plasma and Progenitor Stem Cell Biologics. Its product portfolio meets the highest achievable performance standard at the point of care. It has innovation that remains on the cutting edge of excellence and improves clinical outcomes for patients around the world. More power, versatility, efficiency, and quality at the point of care. EmCyte Corporation is committed to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance the quality of life.